Related Experiment Video
Updated: Jul 5, 2026

08:16
High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
Vascular dysfunction in a murine model of severe hemolysis
Anne C Frei1, YiHe Guo, Deron W Jones
1Blood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin, USA.
Blood
|May 15, 2008
Summary
Mice with hereditary spherocytosis (HS) exhibit vascular dysfunction due to increased plasma hemoglobin. This impairs nitric oxide (NO) availability, leading to abnormal vasoregulation and oxidative damage.
Area of Science:
- Hematology
- Vascular Biology
- Biochemistry
Background:
- Hereditary spherocytosis (HS) in sph/sph mice results from a mutation in the alpha-spectrin gene.
- These mice display severe HS, thrombosis, and infarction, indicating significant vascular dysfunction.
- Previous studies suggest a link between HS and vascular issues, but the underlying mechanisms remain unclear.
Purpose of the Study:
- To investigate pulmonary and systemic vascular dysfunction in sph/sph mice.
- To determine the role of plasma hemoglobin and nitric oxide (NO) scavenging in endothelial injury.
- To explore the contribution of oxidative stress to vascular abnormalities in HS.
Main Methods:
- Analysis of soluble cell adhesion molecules in sph/sph mice plasma.
- Electron paramagnetic resonance spectroscopy to quantify plasma hemoglobin levels.
- Assessment of plasma oxidative potential and xanthine oxidase distribution.
Main Results:
- Elevated levels of soluble cell adhesion molecules indicate vascular endothelium activation.
- Sph/sph mice exhibit significantly higher plasma hemoglobin concentrations.
- Plasma from sph/sph mice demonstrates increased oxidative potential, with altered xanthine oxidase expression.
Conclusions:
- Sph/sph mice show impaired vasoregulation, particularly affecting NO-based mechanisms.
- Increased plasma hemoglobin and NO scavenging capacity contribute to aberrant vasoregulation.
- Oxidative damage initiated by plasma hemoglobin is a key factor in vascular dysfunction in HS.

